Answers are grounded in this paper and cite their sources.
BACKGROUND: Xenograft mouse models play an important role in preclinical cancer research, particularly in the development of new therapeutics. To test the efficacy of a combination therapy consisting of radiation and new drug candidates, it is crucial that only the tumor area is irradiated, while other parts of the body are shielded. In this study, a 3D-printed radiopaque back shield was designed for tumor-specific irradiation and evaluated in a xenograft mouse model. METHODS: Different radiopaque materials were initially tested for their shielding properties using the Multirad 225 X-ray irradiator and the most suitable material was used for printing a back shield with a tumor site-specific opening of the cover. Tumor bearing mice were irradiated four times with a dose of 3.5 Gy. To evaluate proper body shielding, blood samples, spleens and bone marrow were examined at the end of the experiment. RESULTS: A tungsten filament was identified to be most efficient for shielding and used to 3D print a pie-slice-shaped back shield with a tumor-site specific opening, while polylactic acid was used to print a scaffold that ensured proper positioning of the shield. The simple design allowed cost-efficient and fast 3D printing, easy handling and individual modifications of the tumor site openings. In terms of animal safety, the product provided sufficient shielding in the low-dose irradiation protocols of xenograft mice. CONCLUSION: The custom-designed 3D-printed tungsten back shields provide proper shielding of the animals body and allow for subcutaneous tumor irradiation under standardized conditions.
No takes yet. Share an insight, caveat, or question.
Kolz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: